rs199652160

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PP5_ModerateBP4

The NM_007098.4(CLTCL1):​c.988G>A​(p.Glu330Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000633 in 1,613,948 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).

Frequency

Genomes: 𝑓 0.00051 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00065 ( 1 hom. )

Consequence

CLTCL1
NM_007098.4 missense

Scores

10
9

Clinical Significance

Likely pathogenic criteria provided, single submitter P:1U:1

Conservation

PhyloP100: 4.32

Publications

11 publications found
Variant links:
Genes affected
CLTCL1 (HGNC:2093): (clathrin heavy chain like 1) This gene is a member of the clathrin heavy chain family and encodes a major protein of the polyhedral coat of coated pits and vesicles. Chromosomal aberrations involving this gene are associated with meningioma, DiGeorge syndrome, and velo-cardio-facial syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
CLTCL1 Gene-Disease associations (from GenCC):
  • congenital insensitivity to pain with severe intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • multiple congenital anomalies/dysmorphic syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PP5
Variant 22-19234688-C-T is Pathogenic according to our data. Variant chr22-19234688-C-T is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 372327.Status of the report is criteria_provided_single_submitter, 1 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.2646821). . Strength limited to SUPPORTING due to the PP5.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLTCL1NM_007098.4 linkc.988G>A p.Glu330Lys missense_variant Exon 7 of 33 ENST00000427926.6 NP_009029.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLTCL1ENST00000427926.6 linkc.988G>A p.Glu330Lys missense_variant Exon 7 of 33 1 NM_007098.4 ENSP00000441158.1
CLTCL1ENST00000621271.4 linkc.988G>A p.Glu330Lys missense_variant Exon 7 of 32 1 ENSP00000485020.1
CLTCL1ENST00000615606.4 linkn.1008G>A non_coding_transcript_exon_variant Exon 7 of 30 1
CLTCL1ENST00000617103.4 linkn.988G>A non_coding_transcript_exon_variant Exon 7 of 31 1 ENSP00000480709.1

Frequencies

GnomAD3 genomes
AF:
0.000506
AC:
77
AN:
152210
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00222
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000529
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000490
AC:
122
AN:
249198
AF XY:
0.000414
show subpopulations
Gnomad AFR exome
AF:
0.000258
Gnomad AMR exome
AF:
0.000840
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000465
Gnomad NFE exome
AF:
0.000690
Gnomad OTH exome
AF:
0.00132
GnomAD4 exome
AF:
0.000646
AC:
944
AN:
1461620
Hom.:
1
Cov.:
31
AF XY:
0.000648
AC XY:
471
AN XY:
727094
show subpopulations
African (AFR)
AF:
0.000149
AC:
5
AN:
33478
American (AMR)
AF:
0.000961
AC:
43
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86242
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53400
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.000765
AC:
851
AN:
1111816
Other (OTH)
AF:
0.000663
AC:
40
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
48
96
144
192
240
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000505
AC:
77
AN:
152328
Hom.:
0
Cov.:
33
AF XY:
0.000403
AC XY:
30
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41568
American (AMR)
AF:
0.00222
AC:
34
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000529
AC:
36
AN:
68030
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000689
Hom.:
0
Bravo
AF:
0.000990
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.000744
AC:
3
ESP6500EA
AF:
0.000358
AC:
3
ExAC
AF:
0.000513
AC:
62
EpiCase
AF:
0.000927
EpiControl
AF:
0.000593

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Pathogenic:1Uncertain:1
Sep 29, 2016
GeneDx
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The E330K variant in the CLTCL1 gene has been reported previously, in the homozygous state, in three siblingswith significant intellectual disability, global developmental delay, absent pain sensation, self mutilating behavior,ophthalmological abnormalities, hypotonia, bone abnormalities, dysmorphic features, and brain abnormalities onMRI, with childhood death in two of the three siblings (Nahorski et al., 2015). The variant has also been reported inthe presence of another CLTCL1 variant in one individual with autism (Chahrour et al., 2012). The E330K variantwas not observed with any significant frequency in approximately 6200 individuals of European and African Americanancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in thesepopulations. The E330K variant is a non-conservative amino acid substitution, which is likely to impact secondaryprotein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at aposition that is conserved across species and in silico analysis predicts this variant is probably damaging to theprotein structure/function. Therefore, we interpret E330K as a likely pathogenic variant, however, the possibility itmay be a rare benign variant cannot be excluded. -

Oct 29, 2015
OMIM
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.20
.;T
Eigen
Uncertain
0.41
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.96
D;D
M_CAP
Benign
0.0043
T
MetaRNN
Benign
0.26
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.3
M;M
PhyloP100
4.3
PrimateAI
Uncertain
0.57
T
PROVEAN
Uncertain
-2.5
.;D
REVEL
Benign
0.21
Sift
Uncertain
0.0050
.;D
Sift4G
Uncertain
0.0090
D;D
Polyphen
0.80
P;P
Vest4
0.80
MVP
0.40
ClinPred
0.13
T
GERP RS
3.3
Varity_R
0.35
gMVP
0.72
Mutation Taster
=4/96
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199652160; hg19: chr22-19222211; API